Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2024 Earnings Call Transcript February 27, 2025
Organogenesis Holdings Inc. beats earnings expectations. Reported EPS is $0.0971, expectations were $-0.03.
Operator: Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc. At this time, all participants have placed in listen-only mode. Please note that this conference call is being recorded and that the...
